Internal model use may decline under FRTB, banks say

"The jury is still out on whether internal models are worth the effort" – HSBC's Jenkins

mathematics
FRTB means internal models may not be worth the effort, according to banks

Bank risk managers have warned that the use of internal models for calculating regulatory capital is likely to decline as a result of the Basel Committee on Banking Supervision’s Fundamental review of the trading book (FRTB).

"For me personally – and the organisation may feel slightly differently about this, or not – the jury is still out on whether internal models are worth the effort," said Ed Jenkins, global head of wholesale credit and risk at HSBC, speaking on a panel discussion at the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

The new rules of market risk management

Amid 2020’s Covid-19-related market turmoil – with volatility and value-at-risk (VAR) measures soaring – some of the world’s largest investment banks took advantage of the extraordinary conditions to notch up record trading revenues. In a recent Risk.net…

ETF strategies to manage market volatility

Money managers and institutional investors are re-evaluating investment strategies in the face of rapidly shifting market conditions. Consequently, selective genres of exchange-traded funds (ETFs) are seeing robust growth in assets. Hong Kong Exchanges…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here